ATCC Launches First Portal of Whole-genome Sequences Based on Authenticated Biological Standards

MANASSAS, Va., Oct. 1, 2019 /PRNewswire/ — ATCC launched its new ATCC Genome Portal, a publicly available database of reference-quality genome sequences matched to authenticated ATCC biological materials that will help researchers interpret and reproduce their results with confidence. The portal, which launched with an initial 250 genome sequences of widely used bacterial strains, delivers on ATCC’s Enhanced Authentication Initiative, a component of the first of five core pledges under the Incredible 2020 Initiative aimed at increasing reproducibility in biological research.

Current publicly available genomic sequences lack authenticity, quality, completeness, or traceability, which can compromise results. This problem is exacerbated by the absence of standardized methods for developing and validating reference-quality genome sequences.

ATCC addressed this issue by developing a standardized workflow for generating reference-quality genomes. Starting with low-passaged, authenticated ATCC materials and using a standardized next-generation sequencing and hybrid assembly approach, ATCC produced complete reference-quality genomes by combining highly accurate short reads with the scaffolding ability of ultra-long reads. Each step of this workflow undergoes rigorous quality control analyses to ensure that the data proceeding to the next step are the highest quality possible — only data that pass all quality control criteria are published to the ATCC Genome Portal.

“For scientists to accurately interpret their results and make insightful correlations with in silico models, they need access to rigorously validated reference genomes that are tied back to credible biological materials,” said Joseph Leonelli, Ph.D., Vice President, ATCC Federal Solutions. “Through our Enhanced Authentication Initiative, we have identified the key challenges with existing publicly available data and have developed a solution for improving the quality of reference genome sequences. We are excited and proud to be able to offer this resource to the scientific community,” said Dr. Leonelli.

Researchers can download high-quality genome sequences for use in bioinformatic analyses, view annotated data, and search for genomes using their own data. ATCC will continuously update the portal with additional genomes as they become available.

You can register for the ATCC Genome Portal and explore the database by visiting genomes.atcc.org.

About ATCC

ATCC is a premier global biological materials and information resource and standards organization and the leading developer and supplier of authenticated cell lines and microorganisms. With a history of scientific advancements spanning nearly a century, ATCC offers an unmatched combination of being the world’s largest and most diverse collection of biological research solutions and a mission-driven, trusted partner that supports and encourages scientific collaboration. ATCC products, services, and people provide the scientific community with credible biological products, advanced model systems, and custom solutions that support complex research in a variety of innovative applications resulting in incredible achievements in basic science, drug discovery, translational medicine, and public health. ATCC is a non-profit organization with headquarters in Manassas, VA, and an R&D innovation center in Gaithersburg, MD. To learn more about ATCC, visit www.atcc.org.

View original content to download multimedia:http://www.prnewswire.com/news-releases/atcc-launches-first-portal-of-whole-genome-sequences-based-on-authenticated-biological-standards-300928621.html

SOURCE ATCC

Staff

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

2 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

3 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

3 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

4 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

6 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

6 hours ago